The aim of this systematic review is to give an update of all currently available evidence on
the relevance of a geriatric assessment in the treatment of older patients with hematologic …

Background Patients with cancer have an increased risk of malnutrition which is associated
with poor outcome. The Mini Nutritional Assessment (MNA®) is often used in older patients …

Most patients with diffuse large B‐cell lymphoma (DLBCL) are diagnosed at age 60 years or
older. Challenges to effective therapy among older individuals include unfavorable biologic …

Hematologic malignancies (HMs) represent a varied set of diseases ranging from indolent to
aggressive that are increasingly common in the growing older adult population …

Abstract Background American Society of Clinical Oncology guidelines recommend that
patients≥ 65 years of age starting chemotherapy undergo a geriatric assessment (GA) to …

Geriatric assessment (GA) predicts survival among older adults with acute myeloid leukemia
(AML) treated intensively. We evaluated the predictive utility of GA among older adults …

Many older patients with myeloid neoplasms experience treatment-related toxicities. We
previously demonstrated that a home-based, progressive aerobic walking and resistance …

A Frailty and Functionality evaluation for alloHCT was implemented using existing
resources. We describe the implementation of this evaluation across all ages and at first …

Little is known about the characteristics of patients, physicians, and organizations that
influence treatment decisions in older patients with AML. We conducted qualitative …

Objective Hematological treatment decisions in older adults with hematological
malignancies are complex. Our objective is to study the impact of a comprehensive geriatric …